Nedaplatin

Nedaplatin
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	IV
ATC code	none;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name Diammine[(hydroxy-κO)acetato(2-)-κO]platinum;
CAS Number	95734-82-0 ;
PubChem CID	9796440;
ChemSpider	7972206;
UNII	8UQ3W6JXAN;
KEGG	D01416 ;
CompTox Dashboard (EPA)	DTXSID8046878 ;
Chemical and physical data
Formula	C2H8N2O3Pt
Molar mass	303.181 g·mol−1
3D model (JSmol)	Interactive image; coordination form: Interactive image;
	SMILES C(C(=O)[O-])[O-].N.N.[Pt+2]; ; coordination form: O=C1O[Pt-2]([NH3+])([NH3+])OC1;
	InChI InChI=1S/C2H3O3.2H3N.Pt/c3-1-2(4)5;;;/h1H2,(H,4,5);2*1H3;/q-1;;;+2/p-1; Key:GYAVMUDJCHAASE-UHFFFAOYSA-M;
	(verify)

Nedaplatin, sold in Japan as Aqupla (see External Links), is a platinum-based chemotherapy agent. It is toxic to DNA, causing damage to DNA, limiting DNA repair and ultimately limiting DNA synthesis, limiting the propagation of cancer cells.